Analysis of Prognostic Factors and Cancer-Specific Survival in Patients with Undifferentiated and Dedifferentiated Endometrial Carcinoma Undergoing Various Postoperative Adjuvant Therapies

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Silva EG, Deavers MT, Malpica A. Undifferentiated carcinoma of the endometrium: a review. Pathology. 2007;39(1):134–138. doi:10.1080/00313020601159494
   PubMed Web of Science ®Google Scholar
• AlHilli M, Elson P, Rybicki L, et al. Undifferentiated endometrial carcinoma: a National Cancer Database analysis of prognostic factors and treatment outcomes. Int J Gynecol Cancer. 2019;29(7):1126–1133. doi:10.1136/ijgc-2019-000465
   PubMed Web of Science ®Google Scholar
• Cree IA, White VA, Indave BI, Lokuhetty D. Revising the WHO classification: female genital tract tumours. Histopathology. 2020;76(1):151–156. doi:10.1111/his.13977
   PubMed Web of Science ®Google Scholar
• Abu-Rustum N, Yashar C, Arend R, et al. Uterine neoplasms, version 1.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2023;21(2):181–209. doi:10.6004/jnccn.2023.0006
   PubMed Web of Science ®Google Scholar
• Li Z, Zhao C. Clinicopathologic and immunohistochemical characterization of dedifferentiated endometrioid adenocarcinoma. Appl Immunohistochem Mol Morphol. 2016;24(8):562–568. doi:10.1097/PAI.0000000000000232
   PubMedGoogle Scholar
• Hamilton SN, Tinker AV, Kwon J, et al. Treatment and outcomes in undifferentiated and dedifferentiated endometrial carcinoma. J Gynecol Oncol. 2022;33(3):e25. doi:10.3802/jgo.2022.33.e25
   PubMed Web of Science ®Google Scholar
• Yokomizo R, Yamada K, Iida Y, et al. Dedifferentiated endometrial carcinoma: a report of three cases and review of the literature. Mol Clin Oncol. 2017;7(6):1008–1012. doi:10.3892/mco.2017.1437
   PubMedGoogle Scholar
• Murali R, Davidson B, Fadare O, et al. High-grade endometrial carcinomas: morphologic and immunohistochemical features, diagnostic challenges and recommendations. Int J Gynecol Pathol. 2019;38:S40–S63. doi:10.1097/PGP.0000000000000491
   PubMed Web of Science ®Google Scholar
• Tafe LJ, Garg K, Chew I, Tornos C, Soslow RA. Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms. Mod Pathol. 2010;23(6):781–789. doi:10.1038/modpathol.2010.41
   PubMed Web of Science ®Google Scholar
• McGunigal M, Liu J, Kalir T, Chadha M, Gupta V. Survival differences among uterine papillary serous, clear cell and grade 3 endometrioid adenocarcinoma endometrial cancers: a national cancer database analysis. Int J Gynecol Cancer. 2017;27(1):85–92. doi:10.1097/IGC.0000000000000844
   PubMed Web of Science ®Google Scholar
• Ren S, Wu J, Yin W, et al. Researches on the correlation between estrogen and progesterone receptors expression and disease-free survival of endometrial cancer. Cancer Manag Res. 2020;12:12635–12647. doi:10.2147/CMAR.S263219
   PubMed Web of Science ®Google Scholar
• Ceccarelli C, De Leo A, Chieco P, et al. A simple immunohistochemical bio-profile incorporating Bcl2 curbs those cases of invasive breast carcinoma for which an Oncotype Dx characterization is needed. PLoS One. 2019;14(6):e0217937. doi:10.1371/journal.pone.0217937
   PubMed Web of Science ®Google Scholar
• Singh N, Piskorz AM, Bosse T, et al. p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies. J Pathol. 2020;250(3):336–345. doi:10.1002/path.5375
   PubMed Web of Science ®Google Scholar
• Dondi G, Coluccelli S, De Leo A, et al. An analysis of clinical, surgical, pathological and molecular characteristics of endometrial cancer according to mismatch repair status. a multidisciplinary approach. Int J Mol Sci. 2020;21(19):7188. doi:10.3390/ijms21197188
   PubMed Web of Science ®Google Scholar
• Therneau TM, Grambsch PM. Expected Survival. In: Modeling Survival Data: Extending the Cox Model. Statistics for Biology and Health. New York, NY: Springer; 2000:261–287.
   Google Scholar
• Kassambara A, Kosinski M, Biecek P. Survminer: drawing survival curves using “ggplot2”. Available from: https://cran.r-project.org/web/packages/survminer/index.html. Accessed February 26, 2024.
   Google Scholar
• Concin N, Matias-Guiu X, Vergote I, et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer. 2021;31(1):12–39. doi:10.1136/ijgc-2020-002230
   PubMed Web of Science ®Google Scholar
• Tung HJ, Wu RC, Lin CY, Lai CH. Rare subtype of endometrial cancer: undifferentiated/dedifferentiated endometrial carcinoma, from genetic aspects to clinical practice. Int J Mol Sci. 2022;23(7):3794. doi:10.3390/ijms23073794
   PubMed Web of Science ®Google Scholar
• Ganju RG, Tawfik O, Brown L, et al. Undifferentiated endometrial carcinomas: clinicopathologic characteristics and treatment outcomes. Int J Gynecol Cancer. 2018;28(7):1271–1277. doi:10.1097/IGC.0000000000001302
   PubMed Web of Science ®Google Scholar
• Walsh CS, Hacker KE, Secord AA, et al. Molecular testing for endometrial cancer: an SGO clinical practice statement. Gynecol Oncol. 2023;168:48–55. doi:10.1016/j.ygyno.2022.10.024
   PubMed Web of Science ®Google Scholar
• Zhang K, Liu Y, Liu X, et al. Clinicopathological significance of multiple molecular features in undifferentiated and dedifferentiated endometrial carcinomas. Pathology. 2021;53(2):179–186. doi:10.1016/j.pathol.2020.07.015
   PubMed Web of Science ®Google Scholar
• Espinosa I, Lee CH, D’Angelo E, et al. Undifferentiated and dedifferentiated endometrial carcinomas With pole exonuclease domain mutations have a favorable prognosis. Am J Surg Pathol. 2017;41(8):1121–1128. doi:10.1097/PAS.0000000000000873
   PubMed Web of Science ®Google Scholar
• Travaglino A, Raffone A, Mascolo M, et al. TCGA molecular subgroups in endometrial undifferentiated/dedifferentiated carcinoma. Pathol Oncol Res. 2020;26(3):1411–1416. doi:10.1007/s12253-019-00784-0
   PubMed Web of Science ®Google Scholar